Key result
Ivabradine monotherapy successfully restored normal sinus rhythm and normalized ventricular function in two siblings with refractory congenital junctional ectopic tachycardia.
Why the study?
Does ivabradine improve rhythm control and ventricular function in children with refractory congenital junctional ectopic tachycardia?
Case Report (n=2)
No
Does ivabradine improve rhythm control and ventricular function in children with refractory congenital junctional ectopic tachycardia?
Ivabradine may be a highly effective monotherapy for refractory congenital junctional ectopic tachycardia in children, leading to rapid restoration of sinus rhythm and normalization of ventricular function.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for ivabradine in refractory pediatric JET; prospective trials needed before clinical adoption.
Kothari et al. (2018) conducted a case report in Congenital junctional ectopic tachycardia (JET) (n=2). Ivabradine was evaluated on Conversion to normal sinus rhythm and normalization of ventricular function. Ivabradine monotherapy successfully restored normal sinus rhythm and normalized ventricular function in two siblings with refractory congenital junctional ectopic tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: